Natco Pharma Ltd.

NATCO Pharma has informed that the Board of Directors of the Company at their meeting held ON 12th August 2021 have considered and approved the following along with other items of business: Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2021 prepared under Indian Accounting Standards (IND-AS) and as per Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time (‘Listing Regulations’) along with Limited Review Report of the Statutory Auditors. It has enclosed a copy of the same and declared interim dividend of Rs 2 (100%) each per equity share of Rs 2 each for the financial year 2021-22. The date for taking on record of its shareholders eligible for the purpose of payment of interim dividend record date is fixed as Wednesday the 25th day of August, 2021. The payment of said interim dividend will be paid from 31st August 2021. The company is also updating the financial results on the website of the Company. The company has also enclosed press release on Q1 FY 2021-22 results. Meeting commenced at 10.45 am and concluded at 1.00 pm.

The above information is a part of company’s filings submitted to BSE.